Original Article Risk factors for postoperative relapse of chronic rhinosinusitis with nasal polyps and improvement in clinical treatment

被引:0
|
作者
Wang, Wuchen [1 ]
Fu, Junmei [1 ]
Chang, Wenshuai [2 ]
机构
[1] First Peoples Hosp, Dept Otolaryngol, Wuhan 430200, Hubei, Peoples R China
[2] Cent Theater Command PLA, Dept Otolaryngol, Air Force Hosp, Datong 037006, Shanxi, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2024年 / 16卷 / 12期
关键词
Chronic rhinosinusitis; nasal polyps; postoperative relapse; multivariate Logistic regression analysis; EOSINOPHIL CATIONIC PROTEIN; ENDOSCOPIC SINUS SURGERY; RECURRENCE;
D O I
10.62347/CHQV3614
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
: Objectives: To identify the risk factors for postoperative relapse of chronic rhinosinusitis with nasal polyps (CRSwNP) using multivariate Logistic regression analysis and to explore potential improvements in clinical treatment measures. Methods: We selected 270 CRSwNP patients who underwent surgery at The First People's Hospital of Jiangxia District between January 2022 and July 2024. The patients were divided into two groups based on the presence or absence of postoperative relapse: 40 cases with relapse were designated as the relapse group, and the other 230 cases without relapse were designated as the non-relapse group. Serum samples were collected from both groups before surgery to measure eosinophilic cationic protein (ECP)/myeloperoxidase (MPO), immunoglobulin E (IgE), and C-C motif chemokine ligand 4 (CCL4). Receiver operating characteristic (ROC) curves were used to analyze the predictive value of these indices for postoperative relapse in CRSwNP patients. The correlation of these indices with postoperative relapse was analyzed using Spearman's correlation coefficients. Univariate and multivariate analyses were employed to identify factors influencing postoperative relapse of CRSwNP. Results: The relapse group showed markedly higher ECP/MPO, IgE, and CCL4 compared to the non-relapse group. The area under the curve (AUC) for predicting postoperative relapse of CRSwNP by each single indicator approximated 0.800, while the AUC of combined detection was above 0.900. ECP/MPO, IgE, and CCL4 all exhibited a significant positive correlation with postoperative relapse of CRSwNP. Univariate analysis revealed that the postoperative relapse of CRSwNP was significantly linked to the Davos score of nasal polyps, smoking history, postoperative infection, ECP/MPO, IgE, and CCL4. Multivariate analysis confirmed that ECP/MPO, IgE, and CCL4 were independent risk factors for postoperative recurrence of CRSwNP. Conclusions: ECP/MPO, IgE, and CCL4 are reliable predictors of postoperative relapse in CRSwNP patients, and their combined detection can further enhance the predictive accuracy. These biomarkers are closely and positively correlated with postoperative relapse and serve as risk factors for postoperative recurrence. Given the elevated risk of postoperative recurrence in CRSwNP patients with high levels of ECP/MPO, IgE, and CCL4, it is recommended to optimize clinical treatment strategies for these patients to reduce the likelihood of recurrence.
引用
收藏
页码:7609 / 7617
页数:9
相关论文
共 50 条
  • [21] Comparative study of clinical symptoms of chronic rhinosinusitis with nasal polyps patients
    Hu, Jingmin
    Wang, Le
    Ma, Ruixia
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (02)
  • [22] Relationship between serum ECP and TIgE levels and the risk of postoperative recurrence in patients with chronic rhinosinusitis with nasal polyps
    Zhang, Qing
    Li, Hui
    Xie, Di
    Fan, Sijian
    FRONTIERS IN SURGERY, 2025, 11
  • [23] Comparison of Corticosteroids by 3 Approaches to the Treatment of Chronic Rhinosinusitis With Nasal Polyps
    Zhang, Yunyun
    Lou, Hongfei
    Wang, Yang
    Li, Ying
    Zhang, Luo
    Wang, Chengshuo
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (04) : 482 - 497
  • [24] Metabolic syndrome facilitates histopathological changes and the risk of postoperative recurrence in chronic rhinosinusitis with nasal polyps
    Jiang, Tao
    Yu, Tao
    Jiang, Lu
    Qin, Mengyao
    Tong, Zongjing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 128
  • [25] Cost-effectiveness analysis of biologics for the treatment of chronic rhinosinusitis with nasal polyps in Canada
    Yong, Michael
    Kirubalingam, Keshinisuthan
    Desrosiers, Martin Y.
    Kilty, Shaun J.
    Thamboo, Andrew
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01)
  • [26] Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps*
    Kemp, Pieter
    Otten, Josje J.
    Adriaensen, Gwijde F. J. P. M.
    Benoist, Linda B. L.
    Cornet, Marjolein E.
    Hoven, D. Rienk
    Rinia, Bas
    Verkest, Valerie
    Fokkens, Wytske J.
    Reitsma, Sietze
    RHINOLOGY, 2024, 62 (02) : 202 - 207
  • [27] Circulating Exosomal microRNA Profiles Associated with Risk of Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps
    Chen, Siyuan
    Liu, Jia
    Feng, Zhili
    Zhou, Liubo
    Cai, Yuexiang
    Jing, Qiancheng
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 5619 - 5631
  • [28] Comparison of Long-Term Postoperative Outcomes of the Subtypes of Chronic Rhinosinusitis with Nasal Polyps
    Lee, Sang-Min
    Yoo, Shin-Hyuk
    Mo, Ji-Hun
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
  • [29] Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps
    Bai, Junqin
    Huang, Julia H.
    Price, Caroline P. E.
    Schauer, Jacob M.
    Suh, Lydia A.
    Harmon, Regan
    Conley, David B.
    Welch, Kevin C.
    Kern, Robert C.
    Shintani-Smith, Stephanie
    Peters, Anju T.
    Stevens, Whitney W.
    Kato, Atsushi
    Schleimer, Robert P.
    Tan, Bruce K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (02) : 352 - +
  • [30] Clinical Characteristics of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps in Adolescents
    Huang, Chien-Chia
    Chang, Po-Hung
    Huang, Yen-Lin
    Lee, Ta-Jen
    Huang, Chi-Che
    Wu, Pei -Wen
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 1197 - 1206